decamethonium (decamethonium bromide)

Subscribe to Selected New Research on decamethonium

39 relevant articles (0 outcomes, 1 trials/studies) found for this Drug

Description: RN given refers to parent cpd

Also Known As:

decamethonium bromide; (DM)Br2; decamethonium dibromide; decamethonium dichloride; decamethonium dihydroxide; decamethonium diiodide; decamethonium dipricrate; decamethonium iodide; decamethylenebis(trimethylammonium)bromide

Drug Context: Research Results

Organic Chemicals: 40

Amines: 1233

Quaternary Ammonium Compounds: 944

Bis-Trimethylammonium Compounds: 27

Decamethonium Compounds

decamethonium: 39

Onium Compounds

Quaternary Ammonium Compounds: 944

Bis-Trimethylammonium Compounds: 27

Decamethonium Compounds

decamethonium: 39

Related Diseases

1.	Neuromuscular Diseases (Neuromuscular Disease) 06/01/1975 - "Decamethonium and succinylcholine were used to study the effects of depolarizing muscle relaxants on serum potassium in 60 patinets, free of neuromuscular disease, during major orthopedic surgery" Get all the results and reference details, order at left...
2.	Paralysis (Palsy) 08/01/1991 - "In order to investigate further the effects of paralysis on skeletal development in the chick embryo, paralysis was induced at 6 days of incubation by dropping 0.2% solution of decamethonium bromide onto the chorioallantoic membrane and maintaining paralysis through to 20 days of incubation" 11/01/1981 - "Paralysis by injection of decamethonium in conjunction with artificial ventilation did not reveal systematic differences in cardiovascular response threshold, form, or magnitude between the paralyzed and non-paralyzed state, indicating that the cardiovascular response patterns were not secondary to changes in respiration" 04/01/1975 - "Decamethonium iodide at a dose of 1 mg per embryo gave maximum survival and paralysis to 18 days of incubation" 01/01/1953 - "Abolition of decamethonium paralysis of reflex and nerve muscle preparations from the cat.]" 05/01/1998 - "Decamethonium bromide, a neuromuscular blocking agent, was administered to a series of embryos in five dosage groups, producing a cohort of embryos with various degrees of paralysis and atrophy of tendons and muscle" Get all the results and reference details, order at left...
3.	Myasthenia Gravis 01/01/1974 - "A re-evaluation of the decamethonium test for myasthenia gravis." 05/01/1967 - "Desmedt and decamethonium tests in the diagnosis of myasthenia gravis]" 05/01/1952 - "The action of decamethonium iodide (C.10) in myasthenia gravis." 10/01/1956 - "VI. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in patients with myasthenia gravis." 04/01/1953 - "Sensitivity of myasthenia gravis patients to tubocurarine and decamethonium." Get all the results and reference details, order at left...
4.	Seizures (Seizure) 05/07/1949 - "Effects of decamethonium iodide (CIO) on respiration and on induced convulsions in man." 07/01/1983 - "Moreover, dogs receiving central injections of penicillin showed seizures abolished by administration of decamethonium bromide (100 micrograms X kg-1, i.v.)" 02/01/1951 - "Effects of decamethonium bromide (C 10) and d-tubocurarine on electro-convulsions." 05/14/1949 - "Comparison of decamethonium iodide with d-tubocurarine in controlling electrically induced convulsions." Get all the results and reference details, order at left...
5.	Ganglion Cysts (Ganglion) 01/01/1980 - "In order to examine the applicability of this method, we chose the excitatory type of acetylcholine-induced responses of the ganglion cells in Aplysia, and analyzed the mode of inhibition by decamethonium (Deca) and tetraethylammonium (TEA)" 11/01/1986 - "The blocking properties of tubocurarine, decamethonium, hexamethonium and trimetaphan on nicotinic agonists applied by repetitive ionophoretic pulses were examined in rat submandibular ganglion cells using a two-microelectrode voltage-clamp technique at 30 degrees C" 03/01/1970 - "1. When the movement of the nictitating membrane is recorded in the usual way, pulled out under load in cat, dog, or rabbit, end-plate-depolarizing drugs such as succinylcholine, decamethonium, nicotine, and 2268F, cause a retraction.2. This movement is due to activation of orbital striated muscle, as evidenced by the resistance of the movement to ganglion block or excision of the superior cervical ganglion and to administration of phentolamine or atropine, and by its great sensitivity to dimethyltubocurarine.3. End-plate-depolarizing drugs produce contractions of the superior and inferior oblique and of the recti muscles strong enough to account for the movements of the nictitating membrane, provided the known fascial connexions of the orbit allow transmission of a fraction of the extraocular muscle movement to the membrane.4. In post mortem specimens with the front of the orbit undisturbed, retraction of the central end of any of the ocular muscles produces movement of the nictitating membrane; the movement was greatest with the superior oblique and medial rectus" Get all the results and reference details, order at left...
20 Diseases and 39 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Succinylcholine (Suxamethonium Chloride)
2.	Potassium
3.	Neuromuscular Depolarizing Agents
4.	Tubocurarine (Tubocurarine Chloride)
5.	Acetylcholine (Acetylcholine Chloride)
6.	Gallamine Triethiodide (Gallamine)
7.	Bungarotoxins (alpha-Bungarotoxin)
8.	Tacrine (Cognex)
9.	Propidium (Propidium Iodide)
10.	Pancuronium (Pavulon)
42 Drugs and Important Bio-Agents and 26 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Positive-Pressure Respiration (PEEP)
2.	Microelectrodes
2 Therapies and Procedures and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>